Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2021

Aug 5, 2021

30786_dirs_2021-08-05_6d0647d8-093d-4107-aa3a-62b2a0d93688.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-08-04

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-04 Bio-Rad A Common Stock S 327 $760.26 Disposed 919.0531 Direct

Footnotes

F1: Includes 13.1255 and 12.9276 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2021 and 06/30/2021, respectively.